Angiotensin Converting Enzyme (ACE) Inhibitors Strategic Research Report 2024-2030: Increasing Focus on Lifestyle Management and Preventive Care Sustains Demand f
30 oct. 2024 11h48 HE
|
Research and Markets
Dublin, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The "Angiotensin Converting Enzyme (ACE) Inhibitors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The...
Global Antihypertensive Drugs Market Outlook 2023-2030 by Therapy, Type of Drug, and Region
26 juil. 2023 05h08 HE
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The Global Antihypertensive Drugs Market Outlook 2023-2030 report has been added to ResearchAndMarkets.com's offering. The Global Antihypertensive Drugs...
Global Enzyme Inhibitor Markets, Analysis & Forecasts, 2016-2021, 2021-2026F, 2031F: Focus on PPIs, Protease, Reverse Transcriptase, Aromatase, Kinase, Neuraminidase, & Statins
18 oct. 2022 06h33 HE
|
Research and Markets
Dublin, Oct. 18, 2022 (GLOBE NEWSWIRE) -- The "Enzyme Inhibitor Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global enzyme inhibitor market is expected...
Global Kinase Inhibitors Market Report 2021-2026Featuring Major Players - Pfizer, Novartis, AstraZeneca, Bayer, Eisai and Johnson & Johnson
02 juil. 2021 08h08 HE
|
Research and Markets
Dublin, July 02, 2021 (GLOBE NEWSWIRE) -- The "Global Kinase Inhibitors Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for kinase inhibitors should...